GLP-1 and lifting: what the science says about muscle loss risk

What did @traceystimeline actually say?

Honestly? Nothing. The transcript here is song lyrics, not health commentary. The words attributed to this creator, "If you fuck me, they fuck you / And that's the way I like it," are lines from a track playing in the background or being lip-synced, not statements about GLP-1 medications, weight loss, or anything remotely clinical. There is no health claim in this video to fact-check.

This appears to be a lifestyle post tagged with #glp1 and #girlswholift, likely by someone who documents their fitness or weight loss journey. The caption "I think I'll be ok" suggests a mood or milestone moment, not a medical recommendation. Tagging a video #glp1 does not mean the creator made claims about GLP-1 medications.

Does the science back this up?

There is no claim here, so there is no science to evaluate. What we can say is that the GLP-1 category these hashtags reference, which includes semaglutide (Ozempic, Wegovy), tirzepatide (Mounjaro, Zepbound), and liraglutide, has a legitimate and substantial evidence base behind it.

Wilding et al. (2021, New England Journal of Medicine) found semaglutide 2.4mg produced roughly 15% mean body weight reduction over 68 weeks. Jastreboff et al. (2022, NEJM) showed tirzepatide achieved up to 22.5% weight loss at the highest dose. These are real, peer-reviewed outcomes. But none of that science is being invoked, correctly or incorrectly, in this video.

What did they get wrong (or right)?

They got nothing wrong medically because they said nothing medical. The creator did not make a dosing claim, did not compare compounded drugs to brand-name products, did not promise a cure, and did not recommend a protocol. From a fact-checking standpoint, this video is a clean slate.

What is worth noting is the broader context. GLP-1 content on TikTok frequently blurs the line between personal anecdote and implicit endorsement. A video tagged #glp1 with a caption suggesting relief or confidence can function as social proof even without explicit claims. Researchers like Merchant et al. (2023, JAMA Internal Medicine) have documented how wellness content on short-form video platforms shapes drug-seeking behavior even when creators avoid direct recommendations. The absence of a claim is not the same as the absence of influence.

What should you actually know?

If you landed on this fact-check expecting a breakdown of GLP-1 misinformation, here is what actually matters. GLP-1 receptor agonists are prescription medications with real clinical benefits and real side effects. Nausea, vomiting, gastroparesis, and rare risks like pancreatitis and thyroid C-cell tumors in rodent models are documented in prescribing literature. They are not casual supplements.

Compounded versions of semaglutide and tirzepatide circulating during drug shortage periods are not equivalent to FDA-approved brand-name formulations. FormBlends does not treat them as equivalent and neither should you. Anyone considering a GLP-1 medication should consult a licensed provider who can review their full medical history, not make decisions based on a TikTok with 17,700 views and a song lyric in the caption.

The #glp1 hashtag has become a social identity marker as much as an information tag. That is fine. But it means the fact-checking burden falls on the viewer to separate community content from clinical guidance.